Fig. 1From: Rationale and study protocol of ACQUIRE, a prospective, observational study measuring quality of life, treatment preference and treatment satisfaction of autosomal dominant polycystic kidney disease (ADPKD) patients in EuropeStudy Design. ADPKD: autosomal dominant polycystic kidney disease; ADPKD-IS: ADPKD Impact Scale; ADKPD-PDS: ADPKD-Pain and Discomfort Scale; ADPKD-UIS: ADPKD-Urinary Impact Scale; CKD: chronic kidney disease; DCE: discrete choice experiment; SF-12: 12-item Short Form Health Survey; TSQM-9: Abbreviated Treatment Satisfaction Questionnaire for MedicationBack to article page